NCT04190082

Brief Summary

The purpose of this study was to compare BIS (bispectral index) monitoring and clinical sedation scale assessment on the recovery time and propofol usage from deep propofol sedation in children with cerebral palsy who received botulinum toxin injection.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started May 2021

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 4, 2019

Completed
5 days until next milestone

First Posted

Study publicly available on registry

December 9, 2019

Completed
1.4 years until next milestone

Study Start

First participant enrolled

May 1, 2021

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 9, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 9, 2022

Completed
Last Updated

February 15, 2023

Status Verified

February 1, 2023

Enrollment Period

1.6 years

First QC Date

December 4, 2019

Last Update Submit

February 13, 2023

Conditions

Keywords

Cerebral palsyBotulinum toxinBispectral index monitorDeep sedationRecovery

Outcome Measures

Primary Outcomes (1)

  • recovery

    Time taken to recover based on the Physiological CBD score (\>12) from deep sedation

    Immediately after discontinuation of propofol infusion used for botulinum toxin injection

Secondary Outcomes (1)

  • Propofol dose

    Immediately after discontinuation of propofol infusion used for botulinum toxin injection

Study Arms (2)

Group Control

Group who maintains deep sedation using the University of Michigan sedation scale (UMSS) score.

Group BIS

Group who maintain deep sedation using Bispectral Index (BIS) score.

Eligibility Criteria

Age3 Years - 12 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

children with spastic cerebral palsy primary care clinic (rehabilitation)

You may qualify if:

  • years old children with spastic cerebral palsy receiving botulinum toxin injection with deep sedation
  • American Society of Anesthesiologists Physical Status 1-2

You may not qualify if:

  • Body mass index \> 30 kg/m2
  • unstable heart disease
  • Anticipated difficult airway including congenital facial or airway anomaly
  • Recent upper respiratory tract infection ( \< 2 weeks)
  • Gastroesophageal reflux
  • Allergy history to propofol, remifentanil or any drug used during procedure

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Location Yeungnam University Hospita

Daegu, 42415, South Korea

Location

Related Publications (3)

  • Choudhry DK, Brenn BR. Bispectral index monitoring: a comparison between normal children and children with quadriplegic cerebral palsy. Anesth Analg. 2002 Dec;95(6):1582-5, table of contents. doi: 10.1097/00000539-200212000-00020.

  • Malviya S, Voepel-Lewis T, Tait AR. A comparison of observational and objective measures to differentiate depth of sedation in children from birth to 18 years of age. Anesth Analg. 2006 Feb;102(2):389-94. doi: 10.1213/01.ANE.0000184045.01780.73.

  • Saricaoglu F, Celebi N, Celik M, Aypar U. The evaluation of propofol dosage for anesthesia induction in children with cerebral palsy with bispectral index (BIS) monitoring. Paediatr Anaesth. 2005 Dec;15(12):1048-52. doi: 10.1111/j.1460-9592.2005.01658.x.

MeSH Terms

Conditions

Cerebral Palsy

Condition Hierarchy (Ancestors)

Brain Damage, ChronicBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Study Officials

  • Sung Mee Jung, MD,PhD

    Yeungnam University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

December 4, 2019

First Posted

December 9, 2019

Study Start

May 1, 2021

Primary Completion

December 9, 2022

Study Completion

December 9, 2022

Last Updated

February 15, 2023

Record last verified: 2023-02

Data Sharing

IPD Sharing
Will not share

no plan to share our data

Locations